BiotechTube
3PBIOVIAN

3PBIOVIAN

Turku, Finland· Est.
3pbiovian.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $17.5M

Overview

3PBIOVIAN is a Finland-based, global biologics CDMO formed from the merger of 3P Biopharmaceuticals and BIOVIAN, combining over 30 years of combined industry experience. It offers fully integrated development and manufacturing services for proteins, viral vectors, plasmid DNA, and cell therapies, supporting clients from pre-clinical stages to commercial supply. The company positions itself as a flexible, responsive partner with a focus on quality and regulatory compliance, serving biotech and pharmaceutical companies worldwide.

BiologicsAntibodies

Technology Platform

Integrated CDMO platform for biologics manufacturing, covering proteins, viral vectors, plasmid DNA, and cell therapies. Offers end-to-end services from process/analytical development to cGMP clinical and commercial manufacturing for both Drug Substance and Drug Product.

Funding History

2
Total raised:$17.5M
Series A$15M
Seed$2.5M

Opportunities

The global biologics, cell, and gene therapy markets are experiencing rapid growth, driving strong demand for specialized CDMO capacity.
Expansion into high-value services like viral vector and cell therapy manufacturing presents a significant growth avenue.
The trend towards outsourcing by virtual and small biotech firms creates a steady stream of potential clients.

Risk Factors

Faces intense competition from large global and niche CDMOs.
Revenue is dependent on client projects, creating vulnerability to clinical trial failures or cancellations.
High operational and regulatory execution risk, where any significant quality failure could severely damage reputation and business.

Competitive Landscape

Operates in the highly competitive global biologics CDMO market, competing against large players like Lonza, Catalent, and Samsung Biologics, as well as established European specialists like Rentschler Biopharma and FUJIFILM Diosynth. Differentiates through a focus on flexibility, tailored solutions, and integrated services from two European sites.

More companies in Biologics / Biosimilars →More companies in Finland →